Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: A North American brain tumor consortium study Article

Cloughesy, TF, Kuhn, J, Robins, HI et al. (2005). Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: A North American brain tumor consortium study . JOURNAL OF CLINICAL ONCOLOGY, 23(27), 6647-6656. 10.1200/JCO.2005.10.068

Open Access

cited authors

  • Cloughesy, TF; Kuhn, J; Robins, HI; Abrey, L; Wen, P; Fink, K; Lieberman, FS; Mehta, M; Chang, S; Yung, A; DeAngelis, L; Schiff, D; Junck, L; Groves, M; Paquette, S; Wright, J; Lamborn, K; Sebti, SM; Prados, M

sustainable development goals

authors

publication date

  • September 20, 2005

webpage

published in

keywords

  • ADVANCED CANCER
  • FARNESYLTRANSFERASE INHIBITORS
  • GLIOBLASTOMA-MULTIFORME
  • GROWTH
  • GUANOSINE TRIPHOSPHATE
  • Life Sciences & Biomedicine
  • METABOLISM
  • Oncology
  • PACLITAXEL
  • RAS
  • Science & Technology
  • THERAPEUTIC STRATEGY
  • TRANSFERASE INHIBITOR R115777

Location

  • ORLANDO, FL

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 6647

end page

  • 6656

volume

  • 23

issue

  • 27